| Date | State | Bill No. | Title | Outcome |
|---|
| Date | No. | Title | Outcome |
|---|
| Date | Title | Politician |
|---|---|---|
| April 14, 2021 | Timely Reauthorization of Necessary Stem-Cell Programs Lends Access to Needed Therapies Act of 2021 | Rep. Frank Pallone |
| July 25, 2019 | Letter to the Hon. Norman Sharpless, Acting Commissioner of the Food and Drug Administration - Bipartisan E&C Leaders Raise Concerns With FDA Over Proliferation of Unapproved Stem Cell Products | Rep. Frank Pallone |
| June 5, 2019 | Pallone Blasts Fetal Tissue Research Announcement | Rep. Frank Pallone |
| Oct. 26, 2018 | Rep. Chris Smith, Author of 2 Historic Stem Cell Laws, to Be Honored by National Marrow Donor Program | Rep. Chris Smith |
| Sept. 17, 2018 | Letter to Dr. Scott Gottlieb, Commissioner of the Food and Drug Administration - Abraham: HHS Right to Cancel Fetal Tissue Contract | Rep. Chris Smith |
| Date | Title | Politician |
|---|---|---|
| April 14, 2021 | Timely Reauthorization of Necessary Stem-Cell Programs Lends Access to Needed Therapies Act of 2021 | Rep. Frank Pallone |
| July 25, 2019 | Letter to the Hon. Norman Sharpless, Acting Commissioner of the Food and Drug Administration - Bipartisan E&C Leaders Raise Concerns With FDA Over Proliferation of Unapproved Stem Cell Products | Rep. Frank Pallone |
| June 5, 2019 | Pallone Blasts Fetal Tissue Research Announcement | Rep. Frank Pallone |
| Oct. 26, 2018 | Rep. Chris Smith, Author of 2 Historic Stem Cell Laws, to Be Honored by National Marrow Donor Program | Rep. Chris Smith |
| Sept. 17, 2018 | Letter to Dr. Scott Gottlieb, Commissioner of the Food and Drug Administration - Abraham: HHS Right to Cancel Fetal Tissue Contract | Rep. Chris Smith |
| Year(s) | Special Interest Group |
|---|
| Election Date | State | Title | Outcome |
|---|---|---|---|
| Nov. 1, 2007 | New Jersey | Public Question 2: Stem Cell Research Bond Issue | Failed |